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Abstract
Background—Antibiotic prescribing practices among dentists and dental specialists in the 
United States (US) remains poorly understood. The purpose of our study is to compare prescribing 
practices between dental specialties, evaluate the duration of antibiotics prescribed by dentists, and 
determine variation in antibiotic selection among dentists.
Methods—We performed a retrospective cross-sectional analysis of dental provider specialties 
linked to de-identified antibiotic claims data from a large pharmacy benefits manager during the 
2015 calendar year.
Results—As a group, general dentists and dental specialists were responsible for over 2.7 million 
antibiotic prescriptions, higher than several other medical and allied health provider specialties. 
Antibiotic treatment duration was generally prolonged and commonly included broad-spectrum 
agents, such as amoxicillin-clavulanate and clindamycin. Although amoxicillin was the most 
commonly prescribed antibiotic among all dental specialties, there was significant variation among 
other antibiotics selected by each specialty. The most common antibiotic treatment durations were 
for 7 and 10 days.
Conclusions—This study demonstrates that dentists frequently prescribe antibiotics for 
prolonged periods of time and often use broad-spectrum antibiotics. Further studies are necessary 
to evaluate the appropriateness of these antibiotic prescribing patterns.
Practical Implications—The significant variation in antibiotic selection and treatment duration 
identified among all dental specialties in this study population implies that further research and 
guidance into the treatment of dental infections is necessary to improve and standardize antibiotic 
prescribing practices.
Background
Antibiotics are the most commonly used medications for the treatment and prevention of 
bacterial infections, and account for $10.7 billion in healthcare expenditure in the United 
States (US).1, 2 However, antibiotic misuse is widespread in outpatient and inpatient clinical 
settings. For example, the Centers for Disease Control and Prevention (CDC) conservatively 
estimate that 47 million prescriptions for antibiotics (30% of all outpatient antibiotic 
prescriptions) are unnecessary.3 Excessive antibiotic use contributes to the development of 
antibiotic-resistant bacteria, such as Clostridium difficile and carbapenem-resistant 
Enterobacteriaceae, which are recognized as urgent threats to the US healthcare system. 
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Serious antibiotic-resistant bacteria are estimated to cause 23,000 deaths and 2 million 
illnesses in the US annually.1
A number of organizations have initiated strategies to improve antibiotic utilization, 
including the CDC, which has set a national goal to reduce the number of inappropriate 
antibiotic prescriptions by half by the year 2020.4 In 2003, the CDC launched the Get Smart 
about Antibiotics campaign, aimed at educating healthcare providers and consumers about 
appropriate antibiotic prescribing and use.5 More recently, the CDC released guidance to 
hospitals,6 nursing homes,7 and outpatient clinics8 on how to improve antibiotic prescribing 
practices. As of January 1st 2017, The Joint Commission (a national hospital accreditation 
agency in the US) requires that all acute-care hospitals have an antimicrobial stewardship 
program to improve antibiotic prescribing practices.9 Moreover, the Centers for Medicare 
and Medicaid Services (CMS) has proposed formal antibiotic stewardship programs in all 
acute-care hospitals as a condition of participation.10 Many of these initiatives are aimed at 
physicians, but antibiotic prescribing practices by other healthcare providers, including 
dentists, are likely to be closely evaluated in the future.
There is a lack of published data on the antibiotic prescribing practices of dentists. Current 
studies suggest that inappropriate antibiotic prescribing by dentists may be common. For 
example, a self-reported survey of dentists found that 70% of dentists reported inappropriate 
prescription of prophylactic antibiotics prior to a dental procedure.11 Moreover, dentists’ 
adherence to current antibiotic prescribing guidelines likely remain suboptimal. In a case-
based survey, adherence to prescribing guidelines among pediatric dentists in North Carolina 
varied by 10–42%.12 In a UK study of antibiotic prescribing among general dental practices, 
only 19% of antibiotics were prescribed in situations where their use was indicated by 
clinical guidelines. A similar study in the oral surgery acute dental clinic of a major London 
hospital reported only 30% of antibiotic prescriptions complied with clinical guidelines.13
To our knowledge, there has been only one nation-wide epidemiologic investigation of 
antibiotic prescribing practices by dentists in the U.S.14 Roberts et al reported data on the 
number and type of antibiotics prescribed by general dentists. However, there is little data on 
the antibiotic prescribing practices among dental specialists for prophylaxis versus treatment 
purposes and the length of antibiotic treatment courses prescribed by dentists. In this study 
we evaluated the antibiotic prescribing practices of dentists in the US by analyzing dental 
antibiotic prescription claims data for a large nationally representative sample of 
commercially-insured individuals.
Methods
Express Scripts Holding Company (ESHC) is the largest independent prescription benefits 
manager in the United States, with detailed prescription data for over 80 million American 
lives. Data on outpatient antibiotic prescriptions from dentists from January 1, 2015 through 
December 31, 2015 was obtained from the ESHC database. Data included prescribing dental 
provider specialty and location, as well as the prescribed antibiotic’s name, dose, and days’ 
supply (treatment duration). Members with missing claims information, including provider 
information, were excluded. Topical antibiotics, systemic or topical antifungals, 
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antiparasitics, and antivirals were excluded. Antibiotics with the same active ingredient, but 
a different formulation (e.g., extended release tablets) were combined. Antimicrobials with 
antibacterial properties (e.g., methenamine) were included.
Provider specialties were ranked by percentage of total antibiotic prescriptions, and the top 
10 were displayed (Table 1). For this initial analysis, general dentists and all dental 
specialists were grouped together. The number of prescribers, prescriptions, patients, and 
eligible beneficiaries in the database were also obtained. The number of eligible 
beneficiaries was defined as the total number of individuals within the ESHC database at the 
midpoint of the 2015 calendar year. In other words, this value represents the number of 
individuals who are eligible for prescription benefit coverage through ESHC. This number 
does not reflect the number of people who received dental care or filled any antibiotic 
prescriptions. The percentage of total prescribers was calculated by dividing the number of 
providers within each specialty by the total number of prescribers. The percentage of 
antibiotic prescriptions was calculated using a similar method. The number of antibiotic 
prescriptions per prescriber was calculated to evaluate for high-volume antibiotic prescribing 
groups with fewer providers and low-volume antibiotic prescribing groups with several 
providers.
We reviewed the most common antibiotics prescribed by all dental providers and stratified 
the results by dental specialty. The number of dental specialty prescribers, number of 
prescriptions, number of patients, the rate of prescriptions per provider, and the rate ratio of 
antibiotic prescriptions compared to general dentists were analyzed from the available data. 
Antibiotic selection was explored by listing the top 10 most commonly prescribed antibiotics 
for each dental specialty. Pairwise chi-square tests were conducted to compare prescribing 
rates by specialty with general dentists.
Antibiotic treatment duration (number of days) was presented in a histogram. In order to 
distinguish antibiotic prescriptions provided for prophylaxis purposes from those provided 
for treatment purposes we defined antibiotic prophylaxis prescriptions as those written for 
≤1 days’ supply of antibiotics, and we defined treatment prescriptions as those written for >1 
days’ supply of antibiotics. US maps were used to evaluate for variation in state-level 
antibiotic prescribing practices for overall antibiotic use, antibiotic use for prophylaxis, and 
antibiotic use for treatment purposes. Antibiotic prescriptions were calculated by antibiotic 
prescription count per 100,000 eligible beneficiaries in each state to adjust for variation in 
the state population.
The analyses were performed with SAS (v9.4, Cary, NC, USA) and R (v3.3.1). This study 
was approved by the Washington University’s Human Research Protection Office.
Results
A total of 22,299,629 antibiotic prescriptions were prescribed by 866,916 providers out of 
the 38,988,099 eligible member database for the calendar year 2015. On average, 0.57 
antibiotics were prescribed per beneficiary in 2015. Accounting for 17.93% of providers 
(155,462), dentists prescribed the third highest number of antibiotics (2,937,494 
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prescriptions) (Table 1). After adjusting for number of prescriptions per provider, dentists 
prescribed fewer antibiotics than most medical specialties (18.90 prescriptions per provider), 
and ranked ninth among the top 10 antibiotic prescribing specialties by prescription count, 
after obstetric and gynecologic providers (20.72 prescriptions per provider).
When examining antibiotic prescriptions by dental providers only, the most common 
antibiotics prescribed were amoxicillin, clindamycin, penicillin, azithromycin, and 
cephalexin (Figure 1). However, several unusual antibiotics were identified including 
erythromycin, an agent that is no longer recommended in the American Dental Association 
(ADA) guidelines, which was identified as the 10th most-commonly prescribed antibiotic. 
Prescriptions that lack significant antimicrobial activity against typical oral flora were also 
identified. Atypical antibiotics prescribed that are not optimal for treating oral infections 
included drugs like ciprofloxacin (n=14,451; 0.49%), trimethoprim-sulfamethoxazole 
(n=3,318; 0.11%), nitrofurantoin (n=835; 0.03%), and methenamine (n=59; <0.01%).
There was a significant variation in antibiotic prescribing practices by dental specialty (Table 
2). Although general dentists prescribed the highest volume of antibiotics, they had lower 
prescribing rates than some other dental specialists. As a specialty, Oral and Maxillofacial 
Pathology was much more likely to prescribe antibiotics than other dental specialties. Other 
high-volume dental prescribing specialties included Oral and Maxillofacial Surgery, Oral 
and Maxillofacial Radiology, Endodontics, and Periodontics. Orthodontists prescribed the 
fewest antibiotics per prescriber.
All dental providers commonly prescribed broad spectrum antibiotics, such as clindamycin 
and amoxicillin-clavulanate. However, antibiotic prescribing patterns varied by dental 
specialty for several antibiotics (Table 3). For example, periodontists prescribed doxycycline 
more than their peers, whereas orthodontists prescribed azithromycin more often. 
Interestingly, oral and maxillofacial surgeons more frequently prescribed narrower spectrum 
antibiotics such as penicillin and amoxicillin compared to other dental specialties.
A histogram depicting antibiotic prescription duration demonstrated that most antibiotics 
were prescribed for 5, 7, or 10 days (Figure 2a). There were very few prescriptions for fewer 
than 5 days; some prescriptions for 30 days or longer were identified, but these were rare. 
These findings were largely driven by amoxicillin, which showed a similar prescribing 
pattern (Figure 2b). Histograms stratified by common antibiotics demonstrated similar 
findings (Supplemental Figure). Amoxicillin, the most common antibiotic prescribed in our 
data, was generally written for 7 or 10 days. Similar prescribed durations were demonstrated 
for penicillin and amoxicillin-clavulanate. Azithromycin, clindamycin and cephalexin – 
recommended alternatives to amoxicillin for endocarditis prophylaxis – were rarely 
prescribed with fewer than 5 days of supply.
Significant variation in antibiotic prescribing rates are demonstrated by state maps (Figures 
3a, 3b, and 3c). Specifically, overall antibiotic prescribing, and antibiotic prescribing rates 
for treatment, were highest in the southern regions (Alabama, Mississippi, Louisiana, and 
Arkansas) and the Northeast (New York, Massachusetts, and New Jersey). In contrast, 
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prescribing rates for antibiotic prophylaxis were highest in the Great Plains (Kansas, 
Nebraska, Iowa, and South Dakota).
Discussion
To our knowledge, this study is the first to provide national estimates for antibiotic treatment 
selection by both general dentists and dental specialists in the United States. When taken 
together, general dentists and dental specialists are the third highest prescribers of antibiotics 
in the nation by volume. This study is also the first to examine dental antibiotic treatment 
duration in the US. Results of this study suggest that most antibiotics prescribed by dentists 
in the United States are likely for the treatment of odontogenic infections, rather than 
antibiotic prophylaxis. Many treatment courses utilize broad-spectrum agents such as 
amoxicillin-clavulanate and clindamycin. This study demonstrated that dentists occasionally 
prescribed antibiotics unsuited for antibiotic prophylaxis or the treatment of dental infections 
and with spectra of antimicrobial activity suited only for non-dental conditions, such as 
urinary tract infections.
Several studies have previously demonstrated that antibiotic prescribing among dentists is 
comparable to many medical specialties. Using national antibiotic prescribing estimates for 
the US in 2011, Hicks et al. identified that general dentists were responsible for 10% of 
antibiotic prescriptions and were the 4th highest prescriber of antibiotics in the US by 
volume.15 In fact, general dentists in that study prescribed slightly fewer antibiotics than 
pediatricians (12%) and internal medicine physicians (12%). Dentists in other countries also 
contribute to a large percentage of antibiotic prescriptions. For example, dentists provided 
approximately 11.3% of all outpatient antibiotic prescriptions in British Columbia, Canada 
in 201316 and nearly 10% of all antibiotic prescribing in primary care in England.17
Antibiotic prescribing among dentists appears to be increasing in some countries. National 
antibiotic prescribing rates increased by 50% among dental practitioners in Australia 
between 2001 and 2012.18 Similar findings were observed in British Columbia, Canada, 
where dental antibiotic prescribing increased over 60% between 1996 and 2013, whereas 
overall antibiotic prescribing by physicians declined;19 by the end of the study, the 
proportion of all antibiotics prescription by dentists increased from 6.7% to 11.3%. This rise 
in antibiotic prescriptions among dentists may be related to a number of reasons. First, 
individuals may be receiving better access to dental care. Second, dental providers may be 
performing more procedures to salvage infected teeth - rather than performing extractions. 
Finally, as the patient population ages, dental problems are likely becoming more common. 
However, regardless of the prescribing trends, some of these antibiotic prescriptions may be 
unnecessary.
To our knowledge, no studies have evaluated individual dental antibiotic prescriptions to 
determine how often antibiotics are prescribed inappropriately in the US; however, two 
surveys demonstrate that inappropriate antibiotic prescribing is common.11, 12 Furthermore, 
significant geographic variation in antibiotic prescribing practices, suggests that 
inappropriate antibiotic prescribing is a national problem. For example, general dentists in 
the District of Columbia prescribed nearly twice as many antibiotics as general dentists in 
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Delaware.14 In the UK, inappropriate antibiotic prescribing appears to be common.13, 20 For 
example, in a 2016 cross-sectional study analyzing antibiotic prescribing of 568 patients 
among general dentists, less than 20% of antibiotics were prescribed in situations consistent 
with clinical guidelines.21 However, these issues are not limited to just the US and UK, 
inappropriate antibiotic prescribing practices among dentists is a worldwide problem.22–24
Self-described issues that contribute to unnecessary antibiotic prescriptions among dentists 
include antibiotics to treat dental pain associated with periapical abscesses, increase in use 
of dental implants, slow adoption of guidelines, decreasing skill-set of the average dentist, 
use of antibiotics as a substitute for surgery, aging populations, and increased competition 
(more dentists per capita).16, 25 Other important factors include failure of previous operative 
treatment, shortage of clinical time, and patient pressure.21, 26
Inappropriate antibiotic prescriptions have important costs. Unnecessary antibiotic use 
contributes to the selection of multidrug resistant organisms,27 wastes healthcare 
resources,28 and likely leads to a significant number of adverse patient events annually.29, 30 
Thornhill et al. identified that even short antibiotic treatment durations associated with 
endocarditis prophylaxis are associated with adverse reactions, including Clostridium 
difficile.31 Furthermore, narrower spectrum agents, such as amoxicillin had a significantly 
safer side effect profile for patients than clindamycin.
Several investigators have explored methods to improve antibiotic prescribing practices 
among dentists. Through a combination of audit, education and feedback on prescribing 
practices in England, Chate et al. reduced antibiotic use by 43% among 212 general dental 
providers.32 A similar audit, education and feedback intervention in a London hospital 
dental department, improved antibiotic prescribing guideline compliance from 30% to 80%. 
Several other studies have also demonstrated improvements in antibiotic prescribing 
practices after antimicrobial stewardship interventions.13, 20, 33, 34 These audit and feedback 
interventions appear to be well-received by participants. In a follow-up survey after an 
antibiotic audit and feedback intervention, a majority of general dentists found the 
experience to be both understandable and worthwhile.35
Additional studies are required to better evaluate antibiotic prescribing behavior among 
dentists in the US. Specific areas for further investigation include longitudinal prescribing 
trend analyses, evaluations of indeterminate antibiotic treatment durations (e.g., 2–4 days’ 
supply) and prolonged treatment durations (e.g., beyond 10 days), better insights into 
prescriber behavior rationale, and the effect of antimicrobial stewardship interventions – 
such as audit and feedback in the US. Ultimately, improved antibiotic prescribing may likely 
require a combination of clear treatment guidelines by the ADA and/or the CDC along with 
comprehensive antimicrobial stewardship efforts targeted to dental prescribers.
Our study had some limitations. First, despite using one of the largest prescription databases 
available in the US, our cohort only included privately insured Americans and may not be 
generalizable to the entire US population. Specifically, most individuals with commercial 
insurance benefits tend to be younger and employed, married to someone who is employed, 
or the child of someone who has private insurance. Second, only claims that were processed 
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and reimbursed by the payer were included in the analysis. Some enrollees may have paid 
for their antibiotic prescriptions without using their insurance benefits. In particular, shorter 
duration (and less expensive) antibiotic prescriptions, such as antibiotics for prophylaxis 
may be under-represented in our data. Third, the prescription claims data lacked diagnosis or 
indication information. As a result, it was difficult to determine if prolonged antibiotic 
treatment durations were being prescribed for prophylaxis for several days following a 
dental procedure, non-specific conditions such as undifferentiated dental pain, or non-dental 
conditions like sinusitis, upper respiratory tract infections, urinary tract infections, or skin 
and soft tissue infections. Finally, the antibiotic prescriptions in this study are limited to 
those processed by one large pharmacy benefit management company and do not provide a 
complete picture of the antibiotic prescribing patterns for a dental provider. Thus, antibiotic 
prescription rates per provider do not represent the true national prescribing rates for the 
average dental provider.
Conclusions
Our findings suggest that dentists and dental specialists are significant contributors to 
outpatient antibiotic prescriptions in the US. Many of these antibiotic prescriptions are 
written for prolonged periods of time and include broad-spectrum antibiotics. Some 
prescribed antibiotics appear to be for non-dental infections or unsuitable for treating dental 
infections. Further analyses are needed to understand, and eventually improve, antibiotic 
selection practices among dental providers.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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